Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003.
- Domenico Motola, Fabrizio De Ponti, Pasqualino Rossi, Nello Martini, Nicola Montanaro
- British journal of clinical pharmacology
- 2005
Abstract
Introduction Innovation in drug therapy is a source of continuing debate for all those who, for various reasons, are concerned with drugs: manufacturers, regulatory agencies, academia, health care professionals and patients. The term “innovative” often tends to be used to define a new drug proposed for entry onto the market, while it is instead necessary to… (More)